Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 2932 for cancer

Edit search filters
  1. RP2/RP3 In Combination With Atezolizumab And Bevacizumab For The Treatment Of Patients With CRC

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study Of Intravesical BCG In Combination With ALT-803 In Patients With Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Safety And Toxicity Study Of Intravesical Instillation Of TARA-002 In Adults With High-grade, Non-muscle Invasive Bladder Cancer

    Jacksonville, FL, Rochester, MN

  4. Study Of [18F]FAPI-74 PET In Patients With Gastrointestinal Cancers (18F-FAPI-74 GI)

    Rochester, MN

  5. Focused Radiation Versus Systemic Therapy For Kidney Cancer Patients With Limited Metastasis, SOAR Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Advancing Survivorship Support Through Virtual Health Equity Resources For Breast Cancer Responsive Education

    Jacksonville, FL

  7. Study Of DS-1062a In Advanced Or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of Ifinatamab Deruxtecan In Subjects With Pretreated Advanced Or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Empty Bladder Impact During Radiation Therapy For Prostate Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  10. Saruparib (AZD5305) Plus Camizestrant Or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer